---
figid: PMC4381956__nihms674757f1
figtitle: Complement in Monoclonal Antibody Therapy of Cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Saccharomyces cerevisiae
- Candida albicans
- Homo sapiens
pmcid: PMC4381956
filename: nihms674757f1.jpg
figlink: /pmc/articles/PMC4381956/figure/F1/
number: F1
caption: 'Antibody therapy activates complement through the classical pathway, with
  subsequent amplification through the alternative pathway, and complement regulators
  (red text) act on many levels. The components that impact mAb anti-tumor activity
  (circled in blue) have complex effects, and a summary is given below.C1active: Promotes
  mAb induced CDC [, , ].C3: Inhibits T cell proliferation through CR1 signaling [].C3b:
  Prevents ADCC by disrupting mAb interaction with FcγR [].C3a and C5a: Promotes CDC,
  but Induces inflammatory (and possibly tumor-permissive) microenvironment [–, ].DAF
  (CD55), MCP (CD46), and CD59: Prevent CDC, but may also directly block ADCC [–,
  , –].'
papertitle: Complement in Monoclonal Antibody Therapy of Cancer.
reftext: Laura M. Rogers, et al. Immunol Res. ;59(0):203-210.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9358283
figid_alias: PMC4381956__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC4381956__F1
ndex: bd8c2e74-df06-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4381956__nihms674757f1.html
  '@type': Dataset
  description: 'Antibody therapy activates complement through the classical pathway,
    with subsequent amplification through the alternative pathway, and complement
    regulators (red text) act on many levels. The components that impact mAb anti-tumor
    activity (circled in blue) have complex effects, and a summary is given below.C1active:
    Promotes mAb induced CDC [, , ].C3: Inhibits T cell proliferation through CR1
    signaling [].C3b: Prevents ADCC by disrupting mAb interaction with FcγR [].C3a
    and C5a: Promotes CDC, but Induces inflammatory (and possibly tumor-permissive)
    microenvironment [–, ].DAF (CD55), MCP (CD46), and CD59: Prevent CDC, but may
    also directly block ADCC [–, , –].'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - C3
  - C1QA
  - C1QB
  - C1QC
  - C1R
  - C1S
  - SERPING1
  - MBL2
  - MBL3P
  - C4A
  - ERVK-3
  - C4B
  - C2
  - C4BPA
  - C4BPB
  - SCGB2B3P
  - ERVK-2
  - CR1
  - CRIPTO
  - CAPG
  - CD46
  - CD55
  - C5
  - C6
  - C7
  - C9
  - C8A
  - C8B
  - C8G
  - C5AR1
  - CD59
  - VTN
  - IMPACT
  - CFHR1
  - Pfdn4
  - Oog1
  - Serping1
  - Mbl2
  - C4a
  - C4b
  - C4bp
  - ba
  - Scgb2b24
  - Cr2
  - Igkv1-117
  - Cripto
  - Cr1l
  - Cd46
  - Cd55
  - Cd55b
  - Hc
  - Cd59a
  - Vtn
  - Impact
  - Cfhr1
  - C4bpa
  - Cd59b
---
